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Abstract: Although a variety of virus species can infect amphibians, diseases caused by 
ranaviruses ([RVs]; Iridoviridae) have become prominent, and are a major concern for 
biodiversity, agriculture and international trade. The relatively recent and rapid increase in 
prevalence of RV infections, the wide range of host species infected by RVs, the variability 
in host resistance among population of the same species and among different 
developmental stages, all suggest an important involvement of the amphibian immune 
system. Nevertheless, the roles of the immune system in the etiology of viral diseases in 
amphibians are still poorly investigated. We review here the current knowledge of antiviral 
immunity in amphibians, focusing on model species such as the frog Xenopus and the 
salamander (Ambystoma tigrinum), and on recent progress in generating tools to better 
understand how host immune defenses control RV infections, pathogenicity, 
and transmission. 
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1. Introduction 
Amphibians have received much attention during the last two decades because of a now-general 
understanding that more species are at risk of extinction in this class than those of any other classes of 
vertebrates [1]. According to the most recent global assessment completed in 2008 [2], nearly one third 
(32%) of 6,593 amphibian species are threatened with extinction. This number is likely to rapidly 
increase because many amphibian species with highly restricted ranges are located in those tropical 
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regions where die-offs have occurred. What makes the amphibian case so urgent is that these 
organisms are long-term survivors that have persisted through the last four mass extinctions in 
Earth’s history.  
While the causes of the global declines of amphibians are multiple and complex (e.g., habitat 
destruction, introduction of predators/competitors, harmful effects of pesticides or other pollutants, 
climate change, and increase of ultraviolet-B, etc.), infectious diseases now appear to be the proximal 
causes of death in an important number of cases [3,4]. Among amphibian pathogens the chytrid 
fungus,  Batrachochytrium dendrobatidis ( Bd), is currently the largest infectious disease threat to 
biodiversity. Because of the impact of wide-spread die-offs all over the world, Bd has been directly 
linked to extinction of amphibian species [5]. Viral infections by Ranaviruses (RV, family 
Iridoviridae) have also become prominent. Although until recently RVs were considered to cause only 
secondary and limited diseases and dies-off, their prevalence and host-range have recently increased. 
RVs have become the second most widespread infectious diseases of wild and captive amphibians 
worldwide. In a recent comprehensive epizootiology study, RVs were identified as the causative agent 
in approximately half the documented cases of amphibian mortality reported in the United States 
between 1996 and 2001 [6]. Additional compelling evidence of the worldwide distribution, 
diversification, and ongoing expansion of RV infections were presented during the First International 
Symposium on Ranaviruses, Minneapolis MN July 8, 2011 [7–9]. Slides and videos of most 
presentations are available on the symposium website [10]. Thanks to the momentum initiated by the 
symposium, a Global Ranavirus Consortium was created to stimulate interactions among ranavirus 
researchers, and to provide updated information [11]. From these data, it has become clear that RVs 
have the capability of directly contributing to amphibian population declines. Given the emerging 
threat of Bd and RVs to amphibians, the World Organization for Animal Health [12] now requires the 
notification of these infectious diseases [13].  
RVs are large, icosahedral, double stranded DNA viruses with genomes ranging from 105 to 140 kb 
that belong to the Iridoviridae family. RVs are capable of infecting three different classes of 
ectothermic vertebrates: Amphibia, Teleostei, and Reptilia [14], and have fulfilled Koch’s postulates as 
a causative infectious agent of disease. So far, three RV species infecting amphibians have been 
identified based on hosts range distributions, nucleotide sequences comparisons, and protein and RFLP 
profiles [15]. Bohle iridovirus, (BIV), isolated from the native Australian frog, Limnodynastes ornatus, 
remains confined to Australia. Ambystoma tigrinum virus (ATV), initially isolated from salamanders in 
Southern Arizona, infects Ambystomatid salamanders in the US and Canada. In contrast to the 
relatively limited geographic distribution of these two RV species, frog virus 3 (FV3), the main 
member and the type species of the RV genus, and originally isolated from the leopard frog Rana 
pipiens, a native North American species, is now found all over the world in a number of different 
genera and species, potentially making it a serious global threat to amphibians [16].  
Despite the goodly amount of data supporting the important role played by RVs, it remains unclear 
why RVs-associated deaths of amphibian have been noted only recently [15]. In particular, it is 
currently unclear why some species are susceptible, whereas others are tolerant or even resistant to one 
or the other RV pathogens. Given the importance of the host immune system in controlling and 
clearing pathogens, one hypothesis that has been advanced to explain the recent increase in virulence 
and prevalence resulting in mass die-offs is that at least some amphibian species or populations have Viruses 2011, 3                  
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abnormally depressed immune systems, perhaps associated with an environmental “stressor” 
(anthropogenic or otherwise) [17,18]. Therefore, it is urgent to better understand amphibian immune 
responses to RVs and to identify host genes important for disease resistance, as well as to extend 
immunological studies to multiple anuran and urodele species. The current review is intended to 
provide a comprehensive literature on classical and molecular aspects of antiviral responses in 
amphibians with an indication of the knowledge gaps that are essential to fill in order to institute 
effective control and prevention of RV infections.  
2. Organization of the Ectothermic Vertebrate Immune System Compared to Mammals 
Host antiviral immune defenses in ectothermic vertebrates and mammals are fundamentally similar, 
and involve the integration and coordination of two distinct but closely interdependent components: 
the innate and adaptive immune systems [19,20]. Innate immunity provides a rapid, first line of 
defense. It includes the production of type I interferon (IFN) by infected cells, which inhibits virus 
replication by blocking protein synthesis in virus-infected cells and by enhancing natural killer (NK) 
cell-mediated cytotoxicity [21]. Activation of innate immune responses in vertebrates occurs through 
the interaction of germ line-encoded pattern recognition receptors (PRRs) on effector cells that 
recognize molecules specific to pathogens (pathogen-associated molecular patterns [PAMPs]). 
Engagement of PAMPs by the PRRs initiates biochemical cascades that stimulate effector cells and 
that induce the release of soluble mediators reacting against different types of pathogens. Innate 
immunity also includes the release of antimicrobial peptides (AMPs) that are secreted onto the skin 
from granular glands or by immune cells such as macrophages or neutrophils in the blood and tissues, 
as well as serum proteins (including acute phase proteins) and complement components that are 
secreted by the liver [22].  
Effector cells of innate immunity can eliminate infected cells by phagocytosis, release of active 
molecules and cell-mediated cytotoxicity. Among innate effector cells involved in viral immunity are 
NK cells. These large granulocytic leukocytes play an important role based on their ability to directly 
kill infected cells and by producing IFN-γ that has antiviral properties and activates other immune 
cells [23]. In addition, it is known from mammalian studies, that macrophages recruit more phagocytic 
and effector cells to the area of infection by secreting chemokines such as interleukin-8 (IL-8) and 
proinflammatory cytokines that include interleukin-1 (IL-1) and TNF- [17]. Macrophage also 
produce active molecules such as reactive oxygen and nitric oxide (NO) that can directly damage the 
pathogens [24]. We assume that similar cytokines and other active molecules are released in amphibians. 
While the innate system responds rapidly, the adaptive immune system may take several days to 
become fully activated, and requires prior  exposure to an antigen to mount a full immunological 
response, utilizing both cell-mediated and humoral responses. Adaptive immune responses are 
characterized by B and T cells expressing a huge variety of clonal surface Ag-specific receptors, which 
in contrast to germline-encoded innate PRRs, are somatically generated by recombination-activating 
genes (RAG)-dependent gene rearrangements to detect the pathogens and provide the host an 
immunological memory [19]. The vertebrate adaptive immune system is evolutionarily more recent 
than innate immune systems. It appeared near the time of the emergence of jawed vertebrates 
~500 million years ago (MYA) [20]. The adaptive immune response starts by the expansion of the Viruses 2011, 3                  
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antigen-specific T cell clones and their differentiation into effectors. Macrophages are also implicated 
in adaptive immune responses as professional antigen presenting cells (APCs) that can process viral 
antigens through Major Histocompatibility Complex (MHC) class I and class II presentation pathways 
that then activate CD8 and CD4 T cell effectors, respectively [25]. Other APCs that are more efficient 
than macrophages are multiple subsets of dendritic and Langerhans cells. These APCs are well studied 
in mammals but are still poorly defined in ectothermic vertebrates [20]. CD8 T cells give rise to 
cytotoxic T cells (CTLs) that can kill virally-infected cells by recognizing viral antigen peptide 
complexed with MHC class I at their surface. CTLs produce also large amount of IFN-γ and other 
cytokines (e.g., TNF-α). In mammals, CD4 T cells differentiate into various T helper effectors (Th1, 
Th2, Treg, etc.) that produce cytokines important for the production of CTLs (e.g., IL-2) and B cells. 
Although function of mammalian T helper-like cells (e.g., mixed lymphocyte reaction) and many of 
the genes specifying the different CD4 T cell subsets have been identified in bony fish and amphibians, 
the presence and function of these subsets in ectothermic vertebrates is still unclear. The second arm of 
the adaptive immune response is constituted by B cells that differentiate into plasma cells and produce 
antibodies that can directly neutralize the virus or promote antibody-dependent cell-mediated 
cytotoxicity. The peak of the adaptive response usually leads to the clearance of the virus and is 
followed by a contraction phase during which most of the T cell effectors are eliminated by 
programmed cell death, except a minor fraction of memory T cells that can survive for a long time and 
can respond faster to a second infection. There are also memory B cells and long-lived antibody-
secreting plasma cells. The relative importance and interaction of the different immune cells vary 
depending of the virus considered and is still the subject of active research by numerous scientists.  
3. The Xenopus Immune System  
From an evolutionary point of view, Xenopus is one “connecting” taxon that links mammals to 
vertebrates of more ancient origin (bony and cartilaginous fishes) that shared a common ancestor 
~350 MYA [20]. Importantly, Xenopus is a “transitional” animal model, being the oldest vertebrate 
class in which the immunoglobulin (Ig) class switch occurs, but does so in the absence of germinal 
center formation critical for T cell-dependent B-cell maturation in mammals. In addition to its wide 
use for developmental studies, Xenopus has been, and still is frequently used as the nonmammalian 
comparative model of choice for comparative immunological studies. Most of the fundamental 
knowledge about the immune system in amphibians comes from the extensive studies in X. laevis, 
which provided the foundation for the analysis of S. tropicalis genomic sequences, and allowed 
identification of many immunologically-relevant gene homologs. The Xenopus immune system has 
recently been the object of a comprehensive review [20]; here we provide just a succinct summary. 
Studies with X. laevis over several decades have revealed the fundamental conservation of the 
immune system and its high degree of similarity to the mammalian immune system [26]. NK cells and 
most other typical leukocyte types such as neutrophils, basophils, eosinophils, polymorphonuclear 
cells, monocyte and macrophage-like cells, and smaller lymphocytes can be observed in the blood and 
the peritoneal fluid. Although Xenopus lacks  the mammalian equivalent of lymph nodes and 
a lymphopoietic bone marrow, it does have a thymus where T cells differentiate and a spleen that 
represents the main peripheral lymphoid organs where both B and T cells accumulate in the white Viruses 2011, 3                  
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pulp, especially in the follicular area where IgM
+ B cell surrounded by T cells aggregate around a 
central blood vessel [27]. Lymphocytes and other leukocytes also accumulate in the periphery of the 
liver, the kidneys, and along the intestine but without forming the organized lymph nodes as in 
mammals. In contrast to mammalian mature B cells that are generally not phagocytic, peripheral 
differentiated B cells from teleost fish species and X. laevis are phagocytic and capable of killing 
ingested microbes [28]. This finding suggests that evolutionarily, B cells and macrophages may share a 
common origin.  
At the gene level, many of the gene homologs involved in mammalian innate immunity have been 
identified in X. laevis and S. tropicalis [20]. Among them, Toll-like receptors (TLR) are one of the 
innate receptors that recognize PAMPs on pathogens that initiate innate as well as adaptive immune 
responses. Of interest, in contrast to mammals that have 10 TLRs, a total of 20 different TLR genes, as 
well as some adaptor proteins, have been identified in the S. tropicalis genome [29,30]. All these TLR 
genes are constitutively expressed in tadpoles and adults, suggesting that the innate immune response 
through TLR signaling is active throughout life. While most TLRs are evolutionarily conserved due to 
the strong selection for maintenance of specific PAMP recognition, Xenopus TLR4 (i.e., the receptor 
responsible of response to the endotoxin lipopolysaccharide [LPS] in mammals; reviewed in [22]) 
seems to be divergent. In this regard, it is interesting to note that Xenopus is poorly responsive to 
purified LPS (e.g., adult can receive up to 1 mg of LPS without any sign of inflammation or other 
untoward effects) [31]. Thus, Xenopus carries all the human orthologs and some TLR family members 
that are expanded in a Xenopus-specific manner (e.g., TLR14). 
As in mammals, the development and function of the adaptive immune system depend on MHC 
molecules. MHC class I-restricted cytotoxic and MHC class II-restricted helper T cell responses have 
been identified in X. laevis. Most of the molecules that define adaptive immunity (e.g., Igs, T-cell 
receptor [TCR], MHC, RAG, activation-induced cytidine deaminase [AID]) have been 
characterized [20].  Although  putative dendritic cells and Langerhans cells have been described in 
Xenopus adult skin based on morphological criteria and some markers such as MHC class II Ag, and 
vimentin [32], it is not yet known if these cells present antigens. However, APC activity of peritoneal 
macrophages has been characterized [33]. The somatic repertoire of TCRs and Ig receptors are 
generated in a RAG-dependent manner, and B cells produce antibodies of IgM, IgD, IgY 
(IgG-equivalent) and IgX isotypes [34]. IgY is the functional equivalent of mammalian IgG isotype, 
and the thymus dependency of the switch from IgM to IgY is consistent with T helper function [20]. It 
is noteworthy that despite these fundamental similarities of the immune systems of X. laevis and 
mammals, affinity maturation in Xenopus is poor when compared with mammals. For example, the 
affinity of X. laevis IgY antibody against dinitrophenol (DNP), a model antigen, increases less 
than 10 times during a humoral response in contrast to more than a 10,000 fold affinity increase in 
mammals [35,36].  
A unique feature of X. laevis that is likely shared by all anuran species is the presence of distinct 
immune systems in the two developmental life stages, larval and adults, as well as the dramatic 
changes occurring during the metamorphosis. For examples, although both Xenopus larvae and adults 
are immunocompetent and have CD8 T cells, larvae lack significant expression of MHC class I until 
metamorphosis [37]. This strongly suggests an absence of class I-restricted T cell education during 
larval life. Presumably related to the suboptimal expression of MHC class I, NK cells are not detected Viruses 2011, 3                  
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until late in larval stage at the time of metamorphosis [38]. Furthermore, cell-mediated cytotoxicity 
involving either CTLs or NK cells cannot be detected in larvae and becomes significant only several 
weeks after metamorphosis is completed [38]. The relative weakness of the larval adaptive immune 
system extends to antibody production and T helper function, since the switch from IgM to IgY 
antibodies of higher affinity is poor in larvae [34,35]. Therefore, the existing data strongly suggest 
that  the larva displays weak adaptive cell effectors, and thought to rely critically on its innate 
immune system. 
4. Immunity to RVs in Xenopus and Other Anuran Species  
Xenopus provides a powerful experimental model to study immunity to RV diseases since not only 
is its immune system the most extensively characterized of any amphibian, but MHC-defined strains 
and clones as well as a large panel of monoclonal antibodies (and established assays to use them) are 
available [39]. Moreover, at least under laboratory conditions, Xenopus is susceptible to FV3, and 
tadpoles seem less able to defend themselves. The high susceptibility of larval stage to RV infection is 
also documented for other anuran species in natural and captive population. Therefore, comparison in 
Xenopus between susceptible tadpoles and resistant adults to RV infection provides ways to elucidate 
virulence and immune escape mechanisms that are of significant fundamental relevance. 
4.1. Adults  
Initial study revealed that FV3 infection of adult X. laevis is pathogenic (~10−20% of adults 
infected with 10
7 pfu die within a month) [39]. Infected frogs that died exhibit both edema and 
hemorrhages. Frogs that survive the FV3 infection show only transitory signs of pathology 
(e.g.,  lethargy, loss of appetite, cutaneous erythema of the legs, skin shedding). These symptoms 
disappear within a few weeks. Similar symptoms and resistance were also observed using ATV and 
Rana catesbeiana virus Z (RCV-Z), a FV3-like virus [40]. Interestingly, whereas viral DNA is 
detected by PCR in most tissues of infected moribund frogs, the kidney is the primary target of FV3 in 
X. laevis. Immunohistology of tissues from infected frogs using an anti-FV3 monoclonal antibody has 
confirmed that the X. laevis kidney is the primary target of FV3 [41]. Extensive necrosis of proximal 
tubules in parallel with accumulation of detectable viruses is typically observed during early stages of 
infection. We have observed similar resolution of symptoms of infection in a preliminary study with 
FV3 in X. tropicalis. Like X. laevis, the kidney appears to be the main tissue infected in X. tropicalis. 
However, the virus clearance in this organ is considerably slower than it is in X. laevis. (e.g., viral 
DNA still detected four weeks post-infection; [40]). In fact, viral DNA has been detected in a few 
asymptomatic animals 2 months post FV3 infection (Figure 1). This suggests that as in the case of X. 
laevis, quiescence phase of FV3 infection can also occur in X. tropicalis. Despite their overall similar 
morphology,  X. laevis and X. tropicalis belong to distinct evolutionary lineages whose common 
ancestor dates back 60 MYA. The possible conservation of covert infection by FV3 in these two 
species could provide a powerful comparative system of investigation. Viruses 2011, 3                  
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Figure 1. Slow clearance of FV3 DNA in X. tropicalis. FV3 DNA detected by PCR 
(35 cycles) using primers specific for the major capsid protein (MCP) on genomic DNA 
purified from various tissues of outbred X. tropicalis adults that were infected with FV3 by 
i.p. injection of 1 × 10
6 PFU for 2, 6, 13, 27 and 60 days (2 individuals per time point).  
 
 
The kinetics of viral clearance in adult X. laevis, as measured by loss of FV3 DNA, correlates with 
onset of T cell and B cell responses that peak at 6 dpi. Both sub-lethal γ-irradiation-induced thymocyte 
depletion and monoclonal antibody depletion of CD8 T cells markedly increase the susceptibility of 
adults to FV3 infection, indicating the crucial role of CTLs in X. laevis in controlling FV3 
infection [42]. We have further developed a flow cytometry assay using bromodeoxyuridine (BrdU) 
incorporation to assess lymphocyte proliferative responses in vivo, and have detected significant 
proliferation of splenic CD8 T cells 6 days after FV3 infection. Tissue infiltration of activated CD8 T 
cells was monitored by immunohistology. Following primary infection, CD8 T cells significantly 
proliferate in the spleen and accumulate in infected kidneys from day 6 onward in parallel with virus 
clearance (Figure 2). Earlier proliferation and infiltration associated with faster viral clearance were 
observed during a secondary FV3 infection [42]. However, there was a decrease of CD8 T cells 
proliferating in the spleen and infiltrating in the kidneys compared to the primary response. Therefore, 
although these results provide evidence of a protective CD8 T cell response in X. laevis against FV3 as 
well as the occurrence of CD8 T cell memory, they also suggest the involvement of other effector 
mechanisms during a re-infection. For example, it is possible that a more potent antibody response 
becomes prominent during a secondary infection (see below), as is the case for poxvirus [43]. In any 
case, these results provide evidence that amphibians like Xenopus can develop protective 
Ag-dependent CD8 T cell proliferation, recognition, and memory against a natural viral pathogen.  
It is important to mention that so far no specific anti-FV3 IgM or IgY Abs have been detected by 
ELISA in the sera of frogs for up to a month after they were infected for the first time with FV3. 
However, increased mRNA expression of IgY and AID, an enzyme essential for the maturation, 
indicates that B cells are activated during primary FV3 infection [27]. More studies are needed to 
determine if a primary FV3 infection induces antibodies at a too low titer or at a too low affinity to be 
detected by our assay. Nonetheless, specific anti-FV3 IgY Abs are detected after a second viral 
infection (2 to up to 6 months after initial exposure; Figure 2), and viral clearance is markedly Viruses 2011, 3                  
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accelerated (i.e., no viral DNA detectable 3 days post-infection), indicating that protective antibodies 
are generated following a secondary infection [44]. Therefore, when examined in a physiological 
context involving a natural viral pathogen, antibodies generated by X. laevis do appear to provide 
protective defenses against subsequent viral infection even though these antibodies are of a weaker 
affinity than their mammalian counterpart.  
Figure 2. Schematic view of Xenopus adult immune response kinetics in infected kidneys. 
During both primary and secondary FV3 infections, MHC class II+ innate immune cell 
effectors (leukocytes) rapidly accumulate in the kidneys (violet line), the main site of 
infection, and pro-inflammatory genes (e.g., TNF-, IL-1) are induced. This is followed 
by an adaptive CD8 T cell response and infiltration (green line) that peak at 6 dpi during a 
primary infection. During a second FV3 infection, CD8 T cell response and infiltration 
peak 3 days earlier, which suggests T cell memory. However, the lower number of 
infiltrated CD8 T cells (5 time less) suggests that anti-FV3 antibodies (blue line) and B cell 
memory are playing a prominent role during secondary infection resulting in a faster viral 
clearance (red line). 
 
 
Notably, specific antibodies against RVs have been detected in the serum of the marine toad Bufo 
marinus from Australia and Venezuela [45]. Also a prior exposure of bullfrogs (Rana catesbeiana) to 
FV3 (relatively avirulent in this species) protects against a subsequent challenge with RCV-Z, a more 
virulent FV-3-like virus strain [46]. All these observations are consistent with immunological CD8 T 
cell and B cell memory, which means that as in mammals, the adaptive immune system of adult frogs 
provides a faster and more potent protection against a second RV infection. Taken together, these 
results strongly suggest that the clearance of RVs in amphibians involves the host’s adaptive 
immune system. 
Compared to adaptive immunity, much less is known about the role of innate immunity in FV3 
infection. As a first step, we have investigated (using microscopy, flow cytometry and RT-PCR) the 
contribution of peritoneal leukocytes (PLs) in the immune response to FV3 by adult X. laevis [33]. 
Besides the active involvement of NK cells during early stages of FV3 infection (i.e., before the onset 
of T cell responses), our study reveals that macrophages are also involved. The total number and the Viruses 2011, 3                  
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relative abundance of macrophages rapidly increases from 1 to 6 days post-infection, and these cells 
display an activated morphology including phagocytic vacuoles. FV3 infection also induces a rapid 
up-regulation of pro-inflammatory genes including Arginase 1, IL-1 and TNF- that are likely to be 
produced in large part by macrophages. 
Although almost nothing is known about innate immune response to RVs in anuran species other 
than  X. laevis, leukocyte accumulations at the site of infection of Rana temporaria reported on 
necropsies are consistent with the involvement of innate cell effectors [6,47]. Interestingly, several 
antimicrobial peptides produced at the surface of the skin of Rana pipiens and Rana catesbeiana 
inactivate FV3 in vitro, which suggests that these compounds can contribute to innate defenses against 
RV infection [48,49]. As is likely with other facets of innate immunity, AMPs may play an important 
role in inactivating viruses at their portals of entry and controlling infections prior to the onset of 
adaptive immune responses. Moreover, if skin and mucus membrane concentrations of AMPs 
are adversely affected by environmental conditions, then lower levels of these peptides may predispose 
amphibian populations to serious disease. 
4.2. Larvae  
In contrast to adults, Xenopus larvae are considerably more susceptible to FV3, showing more 
than 80% morbidity over 2 months [39]. It is presumed that this reflects immature and/or less efficient 
adaptive effector functions. These include a lack of MHC class I protein expression, which, in 
mammals, is necessary for CTL responses, and antibodies of lower affinity than adult due to the poor 
switch of IgM to IgY. However, the variability of survival times observed between individuals 
suggests that the larval immune system is not completely inactive or ignorant of FV3 infection. 
Furthermore, although Xenopus tadpoles do not express class I until metamorphosis, they do have CD8 
T cells. Whether these cells function immunologically in larvae and are class I unrestricted or 
restricted by nonclassical MHC class I are an interesting research area. 
Several other studies are also consistent with a higher susceptibility of larvae and metamorphs to 
RVs. Unlike Rana pipiens adults that survive infection by injection of 10
6 pfu of FV3, embryos and 
tadpoles succumb to injections of doses as small as 900 pfu [50]. Several RV reported outbreaks 
appear to preferentially affect tadpoles. The massive death reported in ranaculture, the practice of 
farm-raising bullfrogs (R. catesbeiana) for scientific and culinary purposes, also mainly targets 
tadpoles and individuals that have just metamorphosed [51,52].  
So far, our attempts to detect any type of larval Xenopus anti-FV3 immune response have had 
limited success. We have found that as in adults during primary infection, IgY and AID mRNA 
expression is up-regulated in larval B cells. More recently, we developed highly sensitive 
immunoprecipitation and western blotting techniques to detect anti-FV3 IgY antibodies. Preliminary 
results with FV3-immunized tadpoles show that some specific signals can be detected. In addition, 
young adults that were primed and survived FV3 infection at the larval stage developed a typical 
anti-FV3 IgY secondary response upon re-infection [40]. Moreover, prior infection of bullfrog 
tadpoles with relatively avirulent FV3  protects against subsequent challenge with RCV-Z, a more 
virulent FV-3-like virus strain [46]. This suggests that the primary FV3 infection in larvae has 
generated a long lasting thymus-dependent B cell memory, which has persisted through Viruses 2011, 3                  
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metamorphosis. This would imply that tadpoles surviving FV3 infection may become more resistant to 
a secondary infection at the adult stage.  
Besides the observed absence of NK cells until metamorphosis, little is known about innate immune 
responses in larvae. To explore this area we recently investigated the response kinetics of several 
innate immune genes during the early phase of FV3 infection. Using quantitative real-time PCR, we 
found only a modest (10–100 times lower than adults) and delayed (3 days later than adults) 
up-regulation of TNF-α, IL-1β and IFN- genes in leukocytes and in infected tissues, as well as a 
delayed induced expression of the type I IFN-inducible Myxovirus-resistance (Mx) 1 gene. Our study 
suggests that the immaturity of the larval immune system extends to innate effector components, which 
further weaken larval immune defense to RV infections [53]. Immune responses of Xenopus adults and 
larvae are summarized in Table 1. 
Table 1. Summary of immune responses to FV3 in larval and adult X. laevis. 
Adults   
Primary  Secondary  Larvae 
Symptoms 2–3 weeks  3–5 days  Long lasting, >80% death 
Virus Clearance 1 month  1 week  Ineffective 
Innate Immunity      
Cells
1 dpi: Activated 
Mø 
Same + Mø as APC 
Similar to primary 
Mø less resistant to FV3 
No NK 
Induced genes
3 dpi: NK cells 1 
dpi: TNF-, 
IL-1, IFN-, Mx1 
Similar to primary 
Delayed (3 dpi) and 
weaker  
Adaptive T cell immunity      
Splenic CD8 T cell Peak at 6 dpi  
Peak at 3 dpi but lower 
expansion 
? 
CD8 T cell in kidneys At 6 dpi  At 3 dpi but fewer  ? 
T cell memory  -  yes  ? 
Adaptive B cell immunity      
Anti-FV3 antibodies Not detected  IgY from 10 dpi   Not detected 
More IgY mRNAs 6 dpi  3dpi  6–7 dpi 
AID up-regulation 9 dpi   3 dpi  6–7 dpi 
B cell memory -  Yes  Possibly 
Abbreviations: AID: activation-induced cytidine deaminase; dpi: days post-infection; Mø: Macrophages. 
4.3. Complex Role of Xenopus Macrophages in Host Defenses and Viral Persistence  
As mentioned before, in Xenopus as in mammals, macrophages are key cell effectors in both innate 
and adaptive immunity (Figure 3). Of particular interest with regard to viral persistence, our study 
provides evidence of the particular permissiveness of certain PLs to FV3 infection [33]. Notably, the 
persistence of transcriptionally inactive FV3 genomic DNA in PLs may explain the occurrence of 
asymptomatic infection and suggests that FV3 is capable of covert infection. Although some PLs are 
susceptible to FV3 infection as evidenced by apoptotic cells, active FV3 transcription and the detection 
of viral particles by electron microscopy, the infection is weaker (fewer infectious particles), more Viruses 2011, 3                  
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transitory and involves a lower fraction (less than 1%) of PLs than the kidney, the main site of 
infection. However, viral DNA remains detectable in PLs for at least 4 weeks post-infection; this is 
past the point of viral clearance observed in the kidneys.  
Figure 3. Schematic view of the complex role of macrophages in Xenopus host defenses 
against RV. As innate immune cell effectors, macrophage can acquire viral antigen by 
direct infection, pinocytosis of opsonized viruses or phagocytosis of infected cells, as well 
as release cytokines, chemokines and toxins that contribute to limiting the infection. As an 
adaptive immune cell effector, macrophages process and present viral antigens through 
MHC class I and class II pathways, up-regulated co-stimulatory molecules (B7, CD40) and 
activate anti-RV CD8 and CD4 T cells. Finally, macrophage can harbor quiescent RV in 
asymptomatic frogs.  
 
 
Recently, we have developed a multicolor immunofluorescence method to characterize macrophage 
infected by FV3: PLs infected with FV3 in vitro for 2 days  were double stained  with mouse 
anti-HAM56, which recognizes the macrophage antigen HAM56 and specifically cross-reacts with 
Xenopus macrophages [54], and rabbit anti-53R, kindly provided by Dr. V.G. Chinchar that recognizes 
ORF 53R, a putative 54.7-kDa myristoylated viral protein that is critical for FV3 replication [55]. 
A clear co-localization of the viral 53R antigen and the macrophage specific HAM56 was observed in 
a consistent fraction of PLs, which provides direct and clear evidence of macrophage infection by 
FV3 [56]. Notably, FV3 infectivity is lower in PLs than in BHK-21 cells: anti-53R staining is weaker, 
and no assembly sites are detected (Figure 4). 
Taken together these results suggest that although PLs are actively involved in anti-FV3 immune 
responses, some of these cells can be permissive and harbor quiescent, asymptomatic FV3. It is 
currently unknown how common and relevant is the ability of FV3 or other RVs to establish transient 
quiescent infections in their hosts and what are the mechanisms involved. However, subclinical Viruses 2011, 3                  
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infections of several species have been documented, which is consistent with a quiescent phase of RV 
infection [8,57,58].  
Figure 4. Immunofluorescence microscopy of baby hamster kidney cells (BHK, left) and 
Xenopus PLs infected in vitro for 2 days with FV3 (0.3 MOI). Cells were cytocentrifuged 
on microscope slides, fixed with formaldehyde, permeabilized with ethanol, incubated with 
a rabbit anti-53R and FITC-conjugated donkey anti-rabbit Abs (Green); then stained with 
the DNA dye Hoechst-33258 (Blue) mounted in anti-fade medium and visualized with a 
Leica DMIRB inverted fluorescence microscope. Note the large viral assembly sites in 
BHK cells that contain large amount of viral DNA stained Hoechst-33258 and anti-53R Ab 
(arrows). In contrast, anti-53R staining is weaker in PLs, and no assembly sites 
are detected. 
 
4.4. MHC Genotype and Susceptibility to RVs  
In X. laevis there is a single MHC class I gene per genome. Our preliminary comparison among 
X. laevis outbred (putatively MHC heterozygous), and the J and F inbred strains that are MHC 
homozygous for different haplotypes suggests a higher susceptibility of the J homozygous 
genotype [39]. J homozygous adults required twice as long (2-months) to clear the infection compared 
to heterozygous outbreds. The susceptibility of the J strain was even more apparent in tadpoles; 100% 
morbidity occurred within 2 weeks following FV3 infection compared to 80% within 2 months for 
outbred tadpoles. Interestingly, J strain adults seem to have a lower level of MHC class I surface 
expression than other strains or clones examined thus far [59]. This strain could provide an important 
tool for further investigation of a possible association between MHC genotype and host susceptibility 
to FV3 infection.  
The evidence from a natural experiment with Rana temporaria in the field where some ponds have 
been exposed to repeated RV infections for over a decade, whereas others have been free of disease 
over the same period of time, suggest that certain MHC supertypes (i.e., a group of MHC molecules 
that are able to bind overlapping set of peptides with common motifs) are associated with infection 
status (even after accounting for shared ancestry), and the diseased populations have more similar 
supertype frequencies than the uninfected, implying directional selection against the alleles conferring Viruses 2011, 3                  
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greater susceptibility [60]. This finding not only provides genetic evidence for the important 
involvement of the adaptive immune system in anti-FV3, but also indicates that, in the wild, frogs may 
be able to adapt over time to the presence of RVs.  
5. The Immunity to RVs in Salamanders  
Relative to other vertebrate models, the axolotl immune response has often been  described as 
immunodeficient [61]. There are several reasons for this characterization, including: lack of white and 
red pulp compartmentalization of their spleen [62], the production of only two Ig classes, only one of 
which regulates the humoral response and neither of which is anamnestic; no detectable humoral 
response to soluble antigens [63]; antibody titers to horse or sheep erythrocytes reaching a peak only 
two months after priming [64]; chronic rejection of skin allografts, poor mixed lymphocyte reactions 
and relatively weak in vitro proliferative responses to T- and B-cell mitogens, and lack of 
cellular cooperation during the humoral immune response as indicated by enhanced humoral immunity 
following thymectomy or X-ray irradiation [61,65]. In addition, axolotl has an expanded MHC class I 
repertoire (~100 genes) and a non-polymorphic MHC class II [66]. Based primarily on the 
characteristically chronic rejection of allografts and xenografts, weak immune responses appear to 
extend to many other species and genera of salamanders [67]. 
The weakness of the salamander’s immune system is well illustrated by RV infection. Tiger 
salamanders (Ambystoma tigrinum) are highly susceptible to ATV infections with high mortality rates 
both in the laboratory and in the field. In contrast to FV3 infection, where mortality is more common 
in larvae than adults, both larval and adult salamanders succumb to ATV infection, and mortality in 
affected ponds often exceeds 90% [15]. Symptoms are typical of RV infection: lethargy, slow 
movement, red spots or swollen areas near the gills and hind limbs. Hemorrhages and ulceration of the 
skin, edema, swollen and pale livers, and fluid-filled intestines are also seen. Temperature influences 
the extent of mortality and time to death as most salamanders infected at 26 °C survive, whereas lower 
temperatures (10 °C) at which immune responses are likely to be inefficient, result in mortality of 
almost all infected animals [68]. Experimental attempts to determine the host range of ATV 
demonstrated that various salamander species (Ambystoma graciale, A. californiense, Notophthalmus 
viridescens) are susceptible to infection, but bullfrogs (R. catesbeiana) and fish (Gambusia affinis, 
Lepomis cyanellus,  Oncorhynchus mykiss) are resistant to infection [15]. Attempts to determine 
whether antimicrobial peptides are involved in the immune response of tiger salamanders to ATV 
revealed inconsistent effects [69]. Whereas some natural mixtures of peptides from tiger salamanders 
reduced ATV-induced viral plaques, not all preparations of skin peptides were equally effective. 
However, some evidences of innate immune responses in axolotls (Ambystoma mexicanum) has been 
obtained using microarray technology [61]. These limited studies of the Ambystoma defense responses 
to ATV should be considered in the context of the finding that in vivo and  in vitro immune 
responsiveness of urodeles are noticeably less “robust” than those of anurans. Ambystoma mexicanum 
infected with ATV  appears to mount some innate immune response. However, gene expression 
changes indicative of lymphocyte proliferation in the spleen, which is associated with clearance of 
FV3 in adult Xenopus was not detected. Therefore, it has been speculated that ATV may be especially 
lethal to A. mexicanum and related tiger salamanders because they lack proliferative lymphocyte Viruses 2011, 3                  
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responses that are needed to clear highly virulent RVs. However, more direct evidence of lack of 
lymphocyte proliferation during ATV infection (e.g., BrdU incorporation, etc.) is needed before any 
definitive conclusion can be drawn.  
6. Viral Immune Evasion and Virulence Proteins 
Understanding the precise roles that innate and adaptive responses play in anti-ranaviral immunity 
is challenging, but the observation that viruses encode proteins that inhibit specific immune pathways 
provides “biological proof” for the importance of those responses in host defense. Moreover, because 
host antiviral defense mechanisms and virus-encoded virulence genes likely represent different sides of 
the same coin, elucidating key elements of the anti-viral response can benefit from a 
detailed characterization of viral gene functions. 
Virulence/immune evasion genes are genes that facilitate the virus to replication in vivo (and in 
some cases in vitro) by impairing host antiviral responses. Based on analogy with poxviruses and 
herpesviruses, several potential immuno-escape genes have been identified by bioinformatics using 
fully sequenced genome of several RVs [70]. In FV3, candidate immune evasion/virulence genes 
include  a viral homolog of the α subunit of eukaryotic initiation factor eIF-2 (vIF-2α), a CARD 
(caspase recruitment domain-containing protein, vCARD), an hydroxysteroid dehydrogenase homolog 
(vHSD), a viral homolog of the tumor necrosis factor receptor (vTNFR), a ribonuclease  III 
(RNase)-like protein, a cytosine DNA methyltransferase (DMT), and several ORFs encoding putative 
proteins containing immunoglobulin- or MHC-like domains. Moreover, since the aforementioned 
genes were identified by amino acid sequence  identity/similarity with their well-characterized 
mammalian counterparts, it is likely that other, less conserved, immune evasion proteins remain to be 
discovered. Last but not least, two-thirds of these putative gene products share no sequence similarity 
with known viral or eukaryotic proteins, and therefore are of unknown function. Clearly, 
characterizing the precise function of these putative virulence/immune evasion gene homologs and 
identifying potential new RV-specific virulence/immune evasion are important for better 
understanding the success of RV pathogens including their capacity to adapt and expand its host and 
geographic ranges. To reveal functions of putative virulence/immune evasion genes in RVs we have 
recently developed an improved technique to knockout specific genes by homologous recombination 
[71]. The implementation of this improved method to generate FV3 knockout mutants provides a 
powerful way not only to identify viral genes involved in virulence and immune evasion but also to 
develop an attenuated viral vaccine. We have already targeted two FV3 genes: a truncated eIF-2α and 
the immediate early gene 18K. 
The eIF-2α protein subunit is involved in translational control and host interferon downregulation in 
eukaryotic cells. Phosphorylation of eIF-2α leads to the shutdown of the translational machinery of the 
host, which prevents viral replication and therefore is an efficacious method of antiviral defense. 
Viruses must inhibit elevated levels of phosphorylated eIF-2 within the cell to successfully replicate. 
Like poxviruses, most RVs encode vIF-2α, which acts as a pseudosubstrate that binds the antiviral 
protein kinase PKR and prevents the phosphorylation and subsequent inactivation of cellular eIF-2α 
[72]. Consistent with this view, knockout of vIF-2α from ATV leads to increasing pathogenicity and 
sensitivity to interferon [73]. Interestingly, FV3, like shell turtle iridovirus (STIV), only encodes an Viruses 2011, 3                  
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N-terminal truncated version of vIF-2α, which is not able to block PKR activity, and, therefore, was 
assumed to be non-functional [74]. Moreover, FV3 is less virulent for tadpoles than RCV-Z that 
possesses a full-length vIF-2α. To better assess the roles of FV3 genes in virulence and immune 
evasion, we knocked out putative virulence vIF-2α by homologous recombination and assessed their 
roles in replication in vitro and in vivo. Unexpectedly, our observation indicate that the truncated 
vIF-2α is still critically involved in viral growth and virulence in Xenopus tadpoles, since the challenge 
experiments showed that survival of the tadpoles infected with vIF-2α-KO FV3 was significantly 
increased [71]. These results suggest that some feature(s) within this truncated molecule contributes 
to virulence. Although we have not been able to detect a difference in the host immune response, more 
detailed studies of the expression of immune-related genes will be needed to reveal subtle differences 
in antiviral immunity. This study bridges the disciplines of virology and immunology since elucidating 
the identity and function of virus-encoded  immune evasion molecules will likely identify specific 
elements of the host immune response that play critical roles in antiviral immunity. The 18K gene 
encodes an abundant immediate early RV-specific protein of yet unknown function. The recombinant 
FV3 18K KO mutant showed impaired virulence and growth upon infection in Xenopus tadpoles, 
thereby providing the first evidence that this gene is involved in RV virulence [71]. 
7. Role of Host Immune System in Pathogenesis Transmission and Persistence of RV Infections  
Although there is still little direct evidence, host resistance to viral infection may be affected by 
environmental factors, such as temperature, pollutants, habitat modification and invasive species. 
Some of these factors may weaken host immune function directly or indirectly (e.g., stress-related), 
and therefore increase the success of pathogens by enhancing their growth or virulence, as well as their 
dissemination [17,18]. The possible significance of impaired amphibian immune function and resulting 
increased disease susceptibility in global amphibian declines is supported by the survival of some 
amphibian species despite the introduction of pathogens. For example, not all amphibian species are 
susceptible to pathogens of global concern. The American bullfrogs (R. catesbeiana) and X. laevis 
carry Bd infections without significant signs of chytridiomycosis [18]. These findings suggest that 
specific immune defenses are required for protection against pathogens and play a key role in 
population success, rather than success depending on the pathogen's virulence alone. Some populations 
of the same species, more susceptible to RV than others, may be due to different exposure to pollutants 
and/or different stress.  
Among climate related factors, exposure to cold temperature has been reported to impair some 
immune functions of R. pipiens (e.g., lower level complement in the serum, mitogen-induced T cell 
proliferation), although it did not alter host resistance to infection with the bacteria Aeromonas 
hydrophila [75]. Ultraviolet-B radiation (UVB) can be immunosuppressive and has been reported to 
increase amphibian susceptibility to infection, although this is likely to be through a complex and 
unclear combination with other factors [76,77]. Many studies have documented the immunosuppressive 
effects of pollutants such as pesticides, suggesting that environmental contaminants may play a role in 
increased pathogen virulence and disease rates [18]. Laboratory exposure to agricultural pesticides can 
result in inhibitory effects on immune functions of amphibians, such as decreased peripheral leukocyte 
levels, altered spleen cellularity, impaired lymphocyte proliferation responses, and compromised skin Viruses 2011, 3                  
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peptide defenses [18]. Furthermore, chronic exposure to atrazine, a potent endocrine disruptor in 
amphibians, not only interferes with metamorphosis of amphibians, but also alters expression of genes 
involved in immune function and development [78]. The concentration used is this study (400 parts per 
billion) is environmentally relevant since the Environmental Protection Agency’s “Recommended 
Water Quality Criterion” for atrazine is 350 parts per billion. Furthermore, atrazine and several other 
pesticides also alter cellularity and phagocytic activity of X. laevis and lymphocyte proliferation of 
R. pipiens [79]. Exposure to insecticide also increases mortality of A. tigrinum to ATV infection [80]. 
However, it is important to note that there are some perplexing instances in which environmental 
factors is not clearly linked to population declines, particularly in relatively undisturbed areas, such as 
wilderness areas of the western United States, rain forests of Central America and pristine areas in 
Australia.  In most of these cases, infectious diseases seem to be the direct cause of  die-offs in 
amphibians [17]. 
As an alternative way to investigate the relevance of immune status in viral susceptibility and 
dissemination, we developed a cross-infection model in which the adults of X. laevis were 
immunocompromised by sub-lethal γ-irradiation [56]. Our data showed that immunocompromised 
adults as well as immature tadpoles are susceptible to FV3 infection by waterborne transmission from 
both immunocompromised and immunocompetent infected adults with whom they are cohoused. At 
the individual level, impairment of immunity is likely to modify pathogenesis. In X. laevis, we have 
shown that FV3 localization in immunocompetent adults is mostly limited to kidneys, and that FV3 
remains localized to discrete area that are rapidly cleared by the immune response. By contrast, in 
immuncompromised adults, the infecting virus becomes rapidly systemic and spreads to other organs 
like the liver and intestine, and is accompanied by hemorrhages. Such infected animals release 
infectious particles in the water that can infect other interspecific and conspecific animals including 
tadpoles. Although the available data emphasize adaptive immunity, defective components of the 
innate immune system may also contribute to increase host susceptibility to RV infection by 
weakening or delaying the initiation of the adaptive immune response. In this scenario, disease 
outbreaks and decline of amphibian populations associated with RVs are an indirect effect of 
environmental pressures (i.e., “stressors”) on the host immune system.  
Another relevant issue for discussion concerns the potential ability of RV to take advantage of the 
host immune system to persist and increase its dissemination. The viral genes potentially involved in 
immune evasion mentioned at the end of the previous section give a first hint of this possibility. 
Asymptomatic feral adults of different species including X. laevis have been reported to carry RVs. RV 
infection in captive adult anurans may occur without clinical signs or consistent histopathologic lesions. 
In addition, our study in X. laevis has shown that FV3 can infect macrophages and remain 
transcriptionally inactive for up to 3 weeks in these cells. This suggests that FV3 is capable of covert 
infection as are some other iridoviruses in insect [81]. In turn, this type of infection may contribute to 
the dissemination of the disease. Asymptomatic carriers can serve as a viral reservoir that under 
immunocompromising conditions develops a systemic infection that rapidly spreads in a population 
that is subjected to the same immunocompromising conditions.  
Although the susceptibility of various developmental stages of salamanders to RV may differ from 
anurans, data obtained so far are also consistent with a tight dependence of efficient immunity and 
resistance to RVs. Larval salamanders become infectious soon after exposure to ATV. Interestingly, Viruses 2011, 3                  
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atrazine exposure also increases susceptibility to ATV infection in larvae and decreases peripheral 
leukocyte counts in adults [82]. This is an indication that environmental contaminants may have 
immunosuppressive effects on tiger salamanders to ATV infection as it may in anuran species. A 
recent survey of ATV in natural salamander population indicates a relatively high prevalence of the 
virus in animals not associated with morbidity [83]. Therefore, it is possible that ATV may also be able 
of covert infection in salamanders. 
8. Concluding Remarks  
As discussed extensively in this review, there is now compelling evidence for mass deaths among 
amphibian populations resulting from infectious disease outbreaks. Although amphibians have 
effective and diverse immune defense mechanisms, the failure of these defenses to prevent RV 
infection suggests that environmental factors may be compromising the status of their immune system. 
Owing to the increased threat of emerging wildlife viral diseases on global biodiversity, more 
fundamental and comparative research on viral immunity is needed. Extensive studies of amphibian 
immunity have become a key issue if one wants to understand how these viruses can persist, 
disseminate and expand their host ranges. A major challenge in studying antiviral immunity (especially 
adaptive immune responses) in cold blooded vertebrates is the absence of species-specific tools 
(i.e., antibodies and primers specific for immunologically-relevant gene products) and MHC-matched 
host systems. The use of appropriate animal models such as Xenopus and Ambystoma is a critically 
important first step in examining viral-host interactions. However, future studies will need to include 
other amphibian species. New methodologies for global analysis of transcriptomes such as   
high-throughput deep sequencing, combined with the established effective approaches of knock down 
and knock out for RVs, should help unravel complex antiviral mechanisms in amphibians and the 
strategies employed by viruses to avert the immune responses. As the immune systems of ectothermic 
vertebrates become better understood, it is likely that their roles in protecting fish, amphibians, and 
reptiles from RVs infections will become clearer and be utilized to prevent or predict RVs infections.  
Acknowledgments 
The authors thank Nicholas Cohen for valuable discussion and for his critical review of the 
manuscript. Research support: 2 R24 Al 059830-06 from the NIH, and IOS-0923772 and IOS-0742711 
from the NSF.  
Conflict of Interest 
The authors declare no conflict of interest.  
References and Notes 
1.  Stuart, S.N.; Chanson, J.S.; Cox, N.A.; Young, B.E.; Rodrigues, A.S.; Fischman, D.L.;   
Waller, R.W. Status and trends of amphibian declines and extinctions worldwide. Science 2004, 
306, 1783–1786. Viruses 2011, 3                  
 
 
2082
2.  The International Union for Conservation of Nature and Natural Resources (IUCN) Red List of 
Threatened Species (Amphibians). Available online: http://www.iucnredlist.org/initiatives/ 
amphibians (28 October 2011). 
3.  Daszak, P.; Berger, L.; Cunningham, A.A.; Hyatt, A.D.; Green, D.E.; Speare, R. Emerging 
infectious diseases and amphibian population declines. Emerg. Infect. Dis. 1999, 5, 735–748. 
4.  Collins, J.P. Amphibian decline and extinction: What we know and what we need to learn. 
Dis. Aquat. Organ. 2010, 92, 93–99. 
5.  Kilpatrick, A.M.; Briggs, C.J.; Daszak, P. The ecology and impact of chytridiomycosis: An 
emerging disease of amphibians. Trends Ecol. Evol. 2010, 25, 109–118. 
6.  Green, D.E.; Converse, K.A.; Schrader, A.K. Epizootiology of sixty-four amphibian morbidity 
and mortality events in the USA, 1996–2001. Ann. N. Y. Acad. Sci. 2002, 969, 323–339. 
7.  Robert, J.; Gregory Chinchar, V. "Ranaviruses: An emerging threat to ectothermic vertebrates" 
report of the first international symposium on ranaviruses, Minneapolis MN July 8, 2011. 
Dev. Comp. Immunol. 2011, doi:10.1016/j.dci.2011.08.008. 
8.  Lesbarrères, D.; Balseiro, A.; Brunner, J.; Chinchar, V.G.; Duffus, A.; Kerby, J.; Miller, D.L.; 
Robert, J.; Schock, D.M.; Waltzek, T.; et al. Symposium report:Ranavirus: Past, present and 
future. Biol. Lett. 2011, in press. 
9.  Kerby, J. Global focus: 1st international symposium on Ranaviruses. FrogLog 2011, 98, 33–35. 
10. 2011 International Ranavirus Symposium. Available online: http://Fwf.Ag.Utk.Edu/Mgray/ 
Ranavirus/2011ranavirus.htm (accessed on 28 October 2011). 
11.  Global Ranavirus Consortium. Available online: http://fwf.Ag.Utk.Edu/mgray/ranavirus/ 
ranavirus.htm (accessed on 28 October 2011). 
12.  The World Organisation for Animal Health. Available online: http://www.Oie.Int/ (accessed on 
28 October 2011). 
13.  Schloegel, L.M.; Daszak, P.; Cunningham, A.A.; Speare, R.; Hill, B. Two amphibian diseases, 
chytridiomycosis and ranaviral disease, are now globally notifiable to the world organization for 
animal health (oie): An assessment. Dis. Aquat. Organ. 2010, 92, 101–108. 
14. Gray, M.J.; Miller, D.L.; Hoverman, J.T. Ecology and pathology of amphibian ranaviruses. 
Dis. Aquat. Organ. 2009, 87, 243–266. 
15.  Chinchar, V.G.; Hyatt, A.; Miyazaki, T.; Williams, T. Family iridoviridae: Poor viral relations no 
longer. Curr. Top. Microbiol. Immunol. 2009, 328, 123–170. 
16.  Chinchar, V.G. Ranaviruses (family iridoviridae): Emerging cold-blooded killers. Arch. Virol. 
2002, 147, 447–470. 
17.  Carey, C.; Cohen, N.; Rollins-Smith, L. Amphibian declines: An immunological perspective. 
Dev. Comp. Immunol. 1999, 23, 459–472. 
18. Hayes, T.B.; Falso, P.; Gallipeau, S.; Stice, M. The cause of global amphibian declines: A 
developmental endocrinologist's perspective. J. Exp. Biol. 2010, 213, 921–933. 
19.  Workenhe, S.T.; Rise, M.L.; Kibenge, M.J.; Kibenge, F.S. The fight between the teleost fish 
immune response and aquatic viruses. Mol. Immunol. 2010, 47, 2525–2536. 
20.  Robert, J.; Ohta, Y. Comparative and developmental study of the immune system in xenopus. 
Dev. Dyn. 2009, 238, 1249–1270. Viruses 2011, 3                  
 
 
2083
21. Goodbourn, S.; Didcock, L.; Randall, R.E. Interferons: Cell signalling, immune modulation, 
antiviral response and virus countermeasures. J. Gen. Virol. 2000, 81, 2341–2364. 
22. Janeway, C.A., Jr. The immune system evolved to discriminate infectious nonself from 
noninfectious self. Immunol. Today 1992, 13, 11–16. 
23.  Lee, S.H.; Miyagi, T.; Biron, C.A. Keeping nk cells in highly regulated antiviral warfare. Trends 
Immunol. 2007, 28, 252–259. 
24.  Prince, L.R.; Whyte, M.K.; Sabroe, I.; Parker, L.C. The role of tlrs in neutrophil activation. 
Curr. Opin. Pharmacol. 2011, 11, 397–403. 
25.  Viret, C.; Janeway, C.A., Jr. Mhc and t cell development. Rev. Immunogenet. 1999, 1, 91–104. 
26. Du Pasquier, L.; Schwager, J.; Flajnik, M.F. The immune system of xenopus. Annu. Rev. 
Immunol. 1989, 7, 251–275. 
27. Marr, S.; Morales, H.; Bottaro, A.; Cooper, M.; Flajnik, M.; Robert, J. Localization and 
differential expression of activation-induced cytidine deaminase in the amphibian xenopus upon 
antigen stimulation and during early development. J. Immunol. 2007, 179, 6783–6789. 
28.  Li, J.; Barreda, D.R.; Zhang, Y.A.; Boshra, H.; Gelman, A.E.; Lapatra, S.; Tort, L.; Sunyer, J.O.  
B lymphocytes from early vertebrates have potent phagocytic and microbicidal abilities. 
Nat. Immunol. 2006, 7, 1116–1124. 
29.  Ishii, A.; Kawasaki, M.; Matsumoto, M.; Tochinai, S.; Seya, T. Phylogenetic and expression 
analysis of amphibian xenopus toll-like receptors. Immunogenetics 2007, 59, 281–293. 
30.  Roach, J.C.; Glusman, G.; Rowen, L.; Kaur, A.; Purcell, M.K.; Smith, K.D.; Hood, L.E.; Aderem, 
A. The evolution of vertebrate toll-like receptors. Proc. Natl. Acad. Sci. U. S. A. 2005, 102,  
9577–9582. 
31. Bleicher, P.A.; Rollins-Smith, L.A.; Jacobs, D.M.; Cohen, N. Mitogenic responses of frog 
lymphocytes to crude and purified preparations of bacterial lipopolysaccharide (lps). Dev. Comp. 
Immunol. 1983, 7, 483–496. 
32.  Mescher, A.L.; Wolf, W.L.; Moseman, E.A.; Hartman, B.; Harrison, C.; Nguyen, E.; Neff, A.W. 
Cells of cutaneous immunity in xenopus: Studies during larval development and limb 
regeneration. Dev. Comp. Immunol. 2007, 31, 383–393. 
33. Morales, H.D.; Abramowitz, L.; Gertz, J.; Sowa, J.; Vogel, A.; Robert, J. Innate immune 
responses and permissiveness to ranavirus infection of peritoneal leukocytes in the frog xenopus 
laevis. J. Virol. 2010, 84, 4912–4922. 
34.  Du Pasquier, L.; Robert, J.; Courtet, M.; Mussmann, R. B-cell development in the amphibian 
xenopus. Immunol. Rev. 2000, 175, 201–213. 
35. Hsu, E. Mutation, selection, and memory in b lymphocytes of exothermic vertebrates. 
Immunol. Rev. 1998, 162, 25–36. 
36.  Wilson, M.; Hsu, E.; Marcuz, A.; Courtet, M.; Du Pasquier, L.; Steinberg, C. What limits affinity 
maturation of antibodies in xenopus—The rate of somatic mutation or the ability to select 
mutants? EMBO J. 1992, 11, 4337–4347. 
37.  Flajnik, M.F.; Du Pasquier, L. Mhc class i antigens as surface markers of adult erythrocytes 
during the metamorphosis of xenopus. Dev. Biol. 1988, 128, 198–206. Viruses 2011, 3                  
 
 
2084
38.  Horton, T.L.; Stewart, R.; Cohen, N.; Rau, L.; Ritchie, P.; Watson, M.D.; Robert, J.; Horton, J.D. 
Ontogeny of xenopus nk cells in the absence of mhc class i antigens. Dev. Comp. Immunol. 2003, 
27, 715–726. 
39.  Gantress, J.; Maniero, G.D.; Cohen, N.; Robert, J. Development and characterization of a model 
system to study amphibian immune responses to iridoviruses. Virology 2003, 311, 254–262. 
40. Robert, J. Comparative study of infectivity of frog virus 3, rana catesbeiana virus z, and 
ambystoma tigrinum virus in xenopus laevis and xenopus tropicalis. University of Rochester 
Medical Center, Rocherster, NY, USA. Unpublished work, 2011. 
41.  Robert, J.; Morales, H.; Buck, W.; Cohen, N.; Marr, S.; Gantress, J. Adaptive immunity and 
histopathology in frog virus 3-infected xenopus. Virology 2005, 332, 667–675. 
42.  Morales, H.D.; Robert, J. Characterization of primary and memory cd8 t-cell responses against 
ranavirus (fv3) in xenopus laevis. J. Virol. 2007, 81, 2240–2248. 
43. Panchanathan, V.; Chaudhri, G.; Karupiah, G. Antiviral protection following immunization 
correlates with humoral but not cell-mediated immunity. Immunol. Cell Biol. 2010, 88, 461–467. 
44.  Maniero, G.D.; Morales, H.; Gantress, J.; Robert, J. Generation of a long-lasting, protective, and 
neutralizing antibody response to the ranavirus fv3 by the frog xenopus. Dev. Comp. Immunol. 
2006, 30, 649–657. 
45.  Zupanovic, Z.; Lopez, G.; Hyatt, A.D.; Green, B.; Bartran, G.; Parkes, H.; Whittington, R.J.; 
Speare, R. Giant toads bufo marinus in australia and venezuela have antibodies against 
'ranaviruses'. Dis. Aquat. Organ. 1998, 32, 1–8. 
46.  Majji, S.; LaPatra, S.; Long, S.M.; Sample, R.; Bryan, L.; Sinning, A.; Chinchar, V.G. Rana 
catesbeiana virus z (rcv-z): A novel pathogenic ranavirus. Dis. Aquat. Organ. 2006, 73, 1–11. 
47.  Cunningham, A.A.; Tems, C.A.; Russell, P.H. Immunohistochemical demonstration of ranavirus 
antigen in the tissues of infected frogs (rana temporaria) with systemic haemorrhagic or cutaneous 
ulcerative disease. J. Comp. Pathol. 2008, 138, 3–11. 
48.  Chinchar, V.G.; Bryan, L.; Silphadaung, U.; Noga, E.; Wade, D.; Rollins-Smith, L. Inactivation of 
viruses infecting ectothermic animals by amphibian and piscine antimicrobial peptides. Virology 
2004, 323, 268–275. 
49.  Chinchar, V.G.; Wang, J.; Murti, G.; Carey, C.; Rollins-Smith, L. Inactivation of frog virus 3 and 
channel catfish virus by esculentin-2p and ranatuerin-2p, two antimicrobial peptides isolated from 
frog skin. Virology 2001, 288, 351–357. 
50.  Tweedell, K.; Granoff, A. Viruses and renal carcinoma of rana pipiens. V. Effect of frog virus 3 
on developing frog embryos and larvae. J. Natl. Cancer Inst. 1968, 40, 407–410. 
51.  Miller, D.L.; Rajeev, S.; Gray, M.J.; Baldwin, C.A. Frog virus 3 infection, cultured american 
bullfrogs. Emerg. Infect. Dis. 2007, 13, 342–343. 
52.  Mazzoni, R.; de Mesquita, A.J.; Fleury, L.F.; de Brito, W.M.; Nunes, I.A.; Robert, J.; Morales, 
H.; Coelho, A.S.; Barthasson, D.L.; Galli, L.; et al. Mass mortality associated with a frog virus 3-
like ranavirus infection in farmed tadpoles rana catesbeiana from brazil. Dis. Aquat. Organ. 2009, 
86, 181–191. 
53.  Chen, G.; Robert, J. Susceptibility of xenopus laevis tadpoles to infection by the ranavirus frog-
virus 3 correlates with a weak and delayed innate immune response. Eur. J. Immunol. submitted 
for publication, 2011. Viruses 2011, 3                  
 
 
2085
54.  Nishikawa, A.; Murata, E.; Akita, M.; Kaneko, K.; Moriya, O.; Tomita, M.; Hayashi, H. Roles of 
macrophages in programmed cell death and remodeling of tail and body muscle of xenopus laevis 
during metamorphosis. Histochem. Cell Biol. 1998, 109, 11–17. 
55.  Whitley, D.S.; Yu, K.; Sample, R.C.; Sinning, A.; Henegar, J.; Norcross, E.; Chinchar, V.G. Frog 
virus 3 orf 53r, a putative myristoylated membrane protein, is essential for virus replication in 
vitro. Virology 2010, 405, 448–456. 
56.  Robert, J.; George, E.; De Jesus Andino, F.; Chen, G. Waterborne infectivity of the ranavirus frog 
virus 3 in xenopus laevis. Virology 2011, 417, 410–417. 
57. Haislip, N.A.; Gray, M.J.; Hoverman, J.T.; Miller, D.L. Development and disease: How 
susceptibility to an emerging pathogen changes through anuran development. PLoS One 2011, 6, 
e22307. 
58.  Gray, M.J. Are ranaviruses capable of contributing to amphibian species declines? Available 
online: http://fwf.ag.utk.edu/mgray/ranavirus/2011Symposium/Gray.pdf (accessed on 28 October 
2011). 
59.  Flajnik, M.F.; Du Pasquier, L. The major histocompatibility complex of frogs. Immunol. Rev. 
1990, 113, 47–63. 
60.  Teacher, A.G.; Garner, T.W.; Nichols, R.A. Evidence for directional selection at a novel major 
histocompatibility class i marker in wild common frogs (rana temporaria) exposed to a viral 
pathogen (ranavirus). PLoS One 2009, 4, e4616. 
61. Cotter, J.D.; Storfer, A.; Page, R.B.; Beachy, C.K.; Voss, S.R. Transcriptional response of 
mexican axolotls to ambystoma tigrinum virus (atv) infection. BMC Genomics 2008, 9, 493. 
62.  Manning, M.J. Histological organization of the spleen: Implications for immune functions in 
amphibians. Res. Immunol. 1991, 142, 355–359. 
63. Ching, Y.C.; Wedgwood, R.J. Immunologic responses in the axolotl, siredon mexicanum. 
J. Immunol. 1967, 99, 191–200. 
64.  Charlemagne, J. Thymus independent anti-horse erythrocyte antibody response and suppressor t 
cells in the mexican axolotl (amphibia, urodela, ambystoma mexicanum). Immunology 1979, 36, 
643–648. 
65.  Kaufman, J.; Volk, H.; Wallny, H.J. A "minimal essential mhc" and an "unrecognized mhc": Two 
extremes in selection for polymorphism. Immunol. Rev. 1995, 143, 63–88. 
66.  Tournefier, A.; Laurens, V.; Chapusot, C.; Ducoroy, P.; Padros, M.R.; Salvadori, F.; Sammut, B. 
Structure of mhc class i and class ii cdnas and possible immunodeficiency linked to class ii 
expression in the mexican axolotl. Immunol. Rev. 1998, 166, 259–277. 
67.  Cohen, N. Amphibian transplantation reactions. Amer. Zool. 1971, 11, 93–205. 
68.  Rojas, S.; Richards, K.; Jancovich, J.K.; Davidson, E.W. Influence of temperature on ranavirus 
infection in larval salamanders ambystoma tigrinum. Dis. Aquat. Organ. 2005, 63, 95–100. 
69.  Sheafor, B.; Davidson, E.W.; Parr, L.; Rollins-Smith, L. Antimicrobial peptide defenses in the 
salamander, ambystoma tigrinum, against emerging amphibian pathogens. J. Wildl. Dis. 2008, 44, 
226–236. 
70.  Whitley, D.S.; Sample, R.C.; Sinning, A.R.; Henegar, J.; Chinchar, V.G. Antisense approaches for 
elucidating ranavirus gene function in an infected fish cell line. Dev. Comp. Immunol. 2011, 35, 
937–948. Viruses 2011, 3                  
 
 
2086
71.  Chen, G.; Ward, B.M.; Yu, E.K.; Chinchar, V.G.; Robert, J. Improved knockout methodology 
reveals that frog virus 3 mutants lacking either the 18k immediate-early gene or the truncated 
vif2-{alpha} gene are defective for replication and growth in vivo.  J. Virol. 2011,  85,  
11131–11138. 
72.  Langland, J.O.; Cameron, J.M.; Heck, M.C.; Jancovich, J.K.; Jacobs, B.L. Inhibition of pkr by rna 
and DNA viruses. Virus Res. 2006, 119, 100–110. 
73.  Jancovich, J.K.; Jacobs, B.L. Innate immune evasion mediated by the ambystoma tigrinum virus 
eukaryotic translation initiation factor 2alpha homologue. J. Virol. 2011, 85, 5061–5069. 
74. Rothenburg, S.; Chinchar, V.G.; Dever, T.E. Characterization of a ranavirus inhibitor of the 
antiviral protein kinase pkr. BMC Microbiol. 2011, 11, 56. 
75.  Maniero, G.D.; Carey, C. Changes in selected aspects of immune function in the leopard frog, 
rana pipiens, associated with exposure to cold. J. Comp. Physiol. B 1997, 167, 256–263. 
76.  Kiesecker, J.M.; Blaustein, A.R.; Belden, L.K. Complex causes of amphibian population declines. 
Nature 2001, 410, 681–684. 
77. Bancroft, B.A.; Baker, N.J.; Blaustein, A.R. A meta-analysis of the effects of ultraviolet b 
radiation and its synergistic interactions with ph, contaminants, and disease on amphibian 
survival. Conserv. Biol. 2008, 22, 987–996. 
78.  Langerveld, A.J.; Celestine, R.; Zaya, R.; Mihalko, D.; Ide, C.F. Chronic exposure to high levels 
of atrazine alters expression of genes that regulate immune and growth-related functions in 
developing xenopus laevis tadpoles. Environ. Res. 2009, 109, 379–389. 
79.  Christin, M.S.; Menard, L.; Gendron, A.D.; Ruby, S.; Cyr, D.; Marcogliese, D.J.; Rollins-Smith, 
L.; Fournier, M. Effects of agricultural pesticides on the immune system of xenopus laevis and 
rana pipiens. Aquat. Toxicol. 2004, 67, 33–43. 
80.  Kerby, J.L.; Hart, A.J.; Storfer, A. Combined effects of virus, pesticide, and predator cue on the 
larval tiger salamander (ambystoma tigrinum). Ecohealth 2011, doi:10.1007/s10393-011-0682-1. 
81.  Williams, T.; Barbosa-Solomieu, V.; Chinchar, V.G. A decade of advances in iridovirus research. 
Adv. Virus Res. 2005, 65, 173–248. 
82. Forson, D.D.; Storfer, A. Atrazine increases ranavirus susceptibility in the tiger salamander, 
ambystoma tigrinum. Ecol. Appl. 2006, 16, 2325–2332. 
83.  Greer, A.L.; Brunner, J.L.; Collins, J.P. Spatial and temporal patterns of ambystoma tigrinum 
virus (atv) prevalence in tiger salamanders ambystoma tigrinum nebulosum. Dis. Aquat. Organ. 
2009, 85, 1–6. 
© 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 